Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine
暂无分享,去创建一个
D. Griffin | B. Slusher | V. Baxter | C. Rojas | M. Potter | J. Alt | Robert W. Mathey | Victoria K. Baxter
[1] K. Wilcox,et al. Impaired cognitive ability and anxiety-like behavior following acute seizures in the Theiler's virus model of temporal lobe epilepsy , 2014, Neurobiology of Disease.
[2] Avishek Adhikari,et al. Behavioral Neuroscience Mini Review Article Distributed Circuits Underlying Anxiety , 2022 .
[3] Aurel Popa-Wagner,et al. HIV-associated neurocognitive disorders , 2014, Journal of molecular psychiatry.
[4] K. Luan Phan,et al. The contextual brain: implications for fear conditioning, extinction and psychopathology , 2013, Nature Reviews Neuroscience.
[5] B. Slusher,et al. Targeting the Glutamatergic System for the Treatment of HIV-Associated Neurocognitive Disorders , 2013, Journal of Neuroimmune Pharmacology.
[6] T. Krahe,et al. Synaptic Dysfunction in the Hippocampus Accompanies Learning and Memory Deficits in Human Immunodeficiency Virus Type-1 Tat Transgenic Mice , 2013, Biological Psychiatry.
[7] Adam B. Cohen,et al. Eastern Equine Encephalitis in Children, Massachusetts and New Hampshire,USA, 1970–2010 , 2013, Emerging infectious diseases.
[8] H. van Praag,et al. Running throughout middle‐age improves memory function, hippocampal neurogenesis, and BDNF levels in female C57BL/6J mice , 2012, Developmental neurobiology.
[9] Rodney W. Johnson,et al. Influenza Infection Induces Neuroinflammation, Alters Hippocampal Neuron Morphology, and Impairs Cognition in Adult Mice , 2012, The Journal of Neuroscience.
[10] D. Green,et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.
[11] D. Griffin,et al. Alphavirus-Induced Encephalomyelitis: Antibody-Secreting Cells and Viral Clearance from the Nervous System , 2011, Journal of Virology.
[12] E. Kroon,et al. Intracerebral infection with dengue-3 virus induces meningoencephalitis and behavioral changes that precede lethality in mice , 2011, Journal of Neuroinflammation.
[13] H. van Praag,et al. Exercise is not beneficial and may accelerate symptom onset in a mouse model of Huntington’s disease , 2010, PLoS currents.
[14] T. Seyfried,et al. Glutamine targeting inhibits systemic metastasis in the VM‐M3 murine tumor model , 2010, International journal of cancer.
[15] S. Moncada,et al. Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes , 2010, Proceedings of the National Academy of Sciences.
[16] B. Barak,et al. Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis , 2010, Proceedings of the National Academy of Sciences.
[17] J. McArthur,et al. Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap , 2010, Annals of neurology.
[18] T. Scott,et al. Consequences of the Expanding Global Distribution of Aedes albopictus for Dengue Virus Transmission , 2010, PLoS neglected tropical diseases.
[19] S. Weaver,et al. Present and future arboviral threats. , 2010, Antiviral research.
[20] D. Griffin. Emergence and re-emergence of viral diseases of the central nervous system , 2009, Progress in Neurobiology.
[21] B. Kieffer,et al. Activation of nociceptin opioid peptide (NOP) receptor impairs contextual fear learning in mice through glutamatergic mechanisms , 2009, Neurobiology of Learning and Memory.
[22] G. Gronvall. Medical Aspects of Biological Warfare Edited by Zygmunt F. Dembek Falls Church, Virginia: Office of The Surgeon General, United States Army; Washington, DC: Borden Institute, Walter Reed Army Medical Center, 2007. 694 pp., Illustrated. $72.25 (hardcover) , 2009 .
[23] A. Suzumura,et al. Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice. , 2009, The Tohoku journal of experimental medicine.
[24] S. Ritchie,et al. Ecology and geographical expansion of Japanese encephalitis virus. , 2009, Annual review of entomology.
[25] L. White,et al. Extrahippocampal involvement in human herpesvirus 6 encephalitis depicted at MR imaging. , 2008, Radiology.
[26] D. Griffin,et al. Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection , 2008, Proceedings of the National Academy of Sciences.
[27] J Gordon Millichap,et al. Etiologic Classification of Attention-Deficit/Hyperactivity Disorder , 2008, Pediatrics.
[28] Jacqueline N. Crawley,et al. What's Wrong With My Mouse? , 2007 .
[29] A. Savonenko,et al. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer’s disease in a sex-dimorphic pattern , 2006, Neuroscience.
[30] M. Jung,et al. Neural circuits and mechanisms involved in Pavlovian fear conditioning: A critical review , 2006, Neuroscience & Biobehavioral Reviews.
[31] Brian J. Wiltgen,et al. Context Fear Learning in the Absence of the Hippocampus , 2006, The Journal of Neuroscience.
[32] L. Mofenson,et al. A Behavioral and Cognitive Profile of Clinically Stable HIV-Infected Children , 2006, Pediatrics.
[33] M. Bigal. Glutamate Receptor Antagonists , 2004 .
[34] J. Rothstein,et al. Glutamate receptor antagonists protect from virus‐induced neural degeneration , 2004, Annals of neurology.
[35] E. Borden,et al. Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas , 1990, Investigational New Drugs.
[36] D. Griffin,et al. Extensive immune-mediated hippocampal damage in mice surviving infection with neuroadapted Sindbis virus. , 2003, Virology.
[37] Brian J. Wiltgen,et al. The place of the hippocampus in fear conditioning. , 2003, European journal of pharmacology.
[38] M. McCarthy,et al. MK-801 disrupts acquisition of contextual fear conditioning but enhances memory consolidation of cued fear conditioning , 2002, Behavioural pharmacology.
[39] D. Gubler. The global emergence/resurgence of arboviral diseases as public health problems. , 2002, Archives of medical research.
[40] M. Medina,et al. Glutamine and cancer. , 2001, The Journal of nutrition.
[41] D. Griffin,et al. Interferon-γ-Mediated Site-Specific Clearance of Alphavirus from CNS Neurons , 2001, Science.
[42] D. Griffin,et al. Activation of Divergent Neuronal Cell Death Pathways in Different Target Cell Populations during Neuroadapted Sindbis Virus Infection of Mice , 2000, Journal of Virology.
[43] Jacqueline N. Crawley,et al. What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice , 2000 .
[44] Stephen Maren,et al. Muscimol Inactivation of the Dorsal Hippocampus Impairs Contextual Retrieval of Fear Memory , 1999, The Journal of Neuroscience.
[45] D. Griffin,et al. The inflammatory response to nonfatal Sindbis virus infection of the nervous system is more severe in SJL than in BALB/c mice and is associated with low levels of IL-4 mRNA and high levels of IL-10-producing CD4+ T cells. , 1999, Journal of immunology.
[46] R. Paylor,et al. Hippocampal lesions cause learning deficits in inbred mice in the Morris water maze and conditioned-fear task. , 1997, Behavioral neuroscience.
[47] R. Rico-Hesse,et al. Re-emergence of epidemic Venezuelan equine encephalomyelitis in South America , 1996, The Lancet.
[48] A. Spielman,et al. The economic burden imposed by a residual case of eastern encephalitis. , 1995, The American journal of tropical medicine and hygiene.
[49] Joseph E LeDoux,et al. Lesions of the dorsal hippocampal formation interfere with background but not foreground contextual fear conditioning. , 1994, Learning & memory.
[50] W W Souba,et al. Glutamine and Cancer , 1993, Annals of surgery.
[51] J. W. Rudy,et al. Contextual conditioning and auditory cue conditioning dissociate during development. , 1993, Behavioral neuroscience.
[52] D. Griffin,et al. Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis , 1992, Journal of virology.
[53] Joseph E LeDoux,et al. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. , 1992, Behavioral neuroscience.
[54] T. Crawford,et al. Antibody-mediated clearance of alphavirus infection from neurons. , 1991, Science.
[55] J. H. Strauss,et al. Molecular basis of Sindbis virus neurovirulence in mice , 1988, Journal of virology.
[56] D. Griffin,et al. The pathogenesis of spinal cord involvement in the encephalomyelitis of mice caused by neuroadapted Sindbis virus infection. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[57] S Marsoni,et al. The phase II trial. , 1985, Cancer treatment reports.
[58] B. Crabtree,et al. Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. , 1985, Quarterly journal of experimental physiology.
[59] J. Bender,et al. Phase I Trial , 1983 .
[60] J. Koeller,et al. Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses. , 1982, Cancer treatment reports.
[61] J. Kovach,et al. Phase I and pharmacokinetic studies of DON. , 1981, Cancer treatment reports.
[62] E. Casper,et al. Phase I study of 6-diazo-5-oxo-L-norleucine (DON). , 1980, Cancer treatment reports.
[63] J. Olney,et al. Acute dendrotoxic changes in the hippocampus of kainate treated rats , 1979, Brain Research.
[64] C. Cotman,et al. Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells , 1978, Nature.
[65] M. Earnest,et al. Neurologic, intellectual, and psychologic sequelae following western encephalitis , 1971, Neurology.
[66] A. Baker,et al. [Western equine encephalitis]. , 1958, Neurology.
[67] R. E. Cook,et al. Western Equine and St. Louis Encephalitis , 1955, Neurology.
[68] E. H. Lennette,et al. Western equine encephalitis in infants; a report on three cases with sequelae. , 1953, California medicine.